has_role bicalutamide 0 430.06104 430.379 SNOMEDCT:386908000 kegg.drug:D00961 pubmed:30784326 pubmed:31099426 pubmed:17313204 ICI 176334 Kalumid pubmed:12015321 Bicamide ICI 176,334 Bical Calutide CHEBI:3090 Cosudex kegg.compound:C08160 (RS)-bicalutamide pubmed:15509184 racemic bicalutamide Binabic pubmed:12421104 NCIt:C1599 wikipedia.en:Bicalutamide rac-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide Casodex pubmed:19194583 lincs.smallmolecule:LSM-1437 pubmed:12959312 reaxys:5364666 hmdb:HMDB0015260 pubmed:12017896 drugcentral:367 drugbank:DB01128 patent:US4636505 Bypro C18H14F4N2O4S rac-N-[4-cyano-3-(trifluoromethyl)phenyl]-3-[(4-fluorophenyl)sulfonyl]-2-hydroxy-2-methylpropanamide Ormandyl cas:90357-06-5 A racemate comprising of equal amounts of (<i>R</i>)-bicalutamide and (<i>S</i>)-bicalutamide. It is an oral non-steroidal antiandrogen used in the treatment of prostate cancer and hirsutism. bicalutamidum Bicadex Bicalox Bicusan Bicatlon Calumid bicalutamide MESH:C053541 bicalutamida (RS)-4'-cyano-alpha',alpha',alpha',-trifluoro-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methylpropiono-m-toluidide Calutol (+-)-bicalutamide ICI-176334 CHEBI:91617 pubmed:11915584 SNOMEDCT:108766001 pubmed:18062751 pubmed:23527766 chebi_ontology patent:EP100172 antineoplastic agent amide